feed,title,long_url,short_url
MedRxiv,Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico,https://medrxiv.org/cgi/content/short/2022.02.08.22270676v1?rss=1,https://bit.ly/3Ba1Bur
MedRxiv,"DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study",https://medrxiv.org/cgi/content/short/2022.02.08.22270696v1?rss=1,https://bit.ly/3gEEYVv
MedRxiv,"Sero-prevalence of anti-SARS-CoV-2 antibodies in Chattogram Metropolitan Area, Bangladesh",https://medrxiv.org/cgi/content/short/2022.02.09.22270717v1?rss=1,https://bit.ly/365a8Dt
